ALFA FinderBSE filing, NSE: PHARMAID. Summary written from the filing by ALFA Finder's alert engine.
Pharmaids Pharmaceuticals Ltd: key numbers
- Share price
- ₹29.17
- Market cap
- ₹102.9 Cr
- Revenue (annual)
- ₹27.88 Cr
- Net profit (annual)
- ₹-11.72 Cr
- P/E (TTM)
- -24.6×Sector 43.8×
- Promoter holding
- 32.99%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Pharmaids Pharmaceuticals Ltd
All →Pharmaids Pharmaceuticals Q2 FY27 Results: Net Loss of ₹1.8 Cr, Loss Narrows
Pharmaids Pharmaceuticals Ltd reported revenue from operations of ₹4.3 Cr (-50.0% YoY) and a net loss of ₹1.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹1.8 Cr
Pharmaids Pharmaceuticals Other Announcement
Pharmaids Pharmaceuticals Limited filed its quarterly Regulation 74(5) compliance certificate from its Registrar and Share Transfer Agent confirming the dematerialization of shares.
Pharmaids Pharmaceuticals Legal & Regulatory
Pharmaids Pharmaceuticals filed legal complaints against Anugraha Chemicals for dishonoured cheques totalling ₹2.63 Crore in outstanding dues from a disinvestment agreement.
- Value
- ₹2.63 Cr
Pharmaids Pharmaceuticals Annual General Meeting
Pharmaids Pharmaceuticals held its 37th AGM via video conference on 11 Sept 2026. Four resolutions including adoption of FY26 financials and related-party-transaction approvals were tabled.
Pharmaids Pharmaceuticals Promoter Buying (Off-Market)
KMP Prasanna Subramanya Bhat acquired 17,291 shares of Pharmaids Pharmaceuticals Ltd via a gift from an immediate relative. This off-market transfer is an insider disclosure.
- Promoter stake change
- +0.04%
Pharmaids Pharmaceuticals Annual General Meeting
Pharmaids Pharmaceuticals Limited has issued the notice for its 37th Annual General Meeting, scheduled for September 11, 2026, along with the Annual Report for 2025-26.
Other board meeting date announcements
All →Associated Ceramics Board Meeting Date
Associated Ceramics has scheduled a board meeting on November 14, 2026 to consider unaudited standalone September 2026 half-yearly results. Advance notice; meeting not yet held.
Dudani Retail Board Meeting Date
Dudani Retail has given intimation of a board meeting on 14 November 2026 to consider unaudited half-year standalone results and related statements. The trading window stays closed until 48 hours after the results are declared.
Davin Sons Retail Board Meeting Date
Davin Sons Retail will hold a board meeting on 14 November 2026 to consider half-year results and a registered office shift. No amount is stated.
Shine Fashions (India) Board Meeting Date
Shine Fashions (India) has given prior intimation of a board meeting on 14 November 2026 to consider half-year results and a preferential fund raise. Trading window has been closed since 1 October 2026.
Gautam Exim Board Meeting Date
Gauam Exim will hold a board meeting on 14 November 2026 to consider unaudited half-year results. Trading window closes 30 November 2026, having opened 1 November 2026.
Sollfege Smart Electronics Board Meeting Date
Sollfege Smart Electronics will hold a board meeting on 14 November 2026 to consider unaudited half-year results. Trading window closes 8 to 15 November 2026.